Intellectual Property India Publishes Patent Application for 'Benzopyrimidin-4(3h)-Ones As Pi3k Inhibitors' Filed by Onkure, Inc.

MUMBAI, India, Feb. 21 -- Intellectual Property India has published a patent application (202517000444 A) filed by Onkure, Inc., Boulder, U.S.A., on Jan. 2, for 'benzopyrimidin-4(3h)-ones as pi3k inhibitors.'

Inventor(s) include Blake, James, F.; Boys, Mark, Laurence; Mareska, David, A.; Payette, Joshua, Nathaniel; Schulte, Christie, A.; Yestrepsky, Bryan; and Zhao, Qian.

The application for the patent was published on Feb. 21, under issue no. 08/2025.

According to the abstract released by the Intellectual Property India: "Novel PI3K inhibitors of the general Formula (1) are described along with methods of their preparation and their use in the treatment of diseases associated with the elevation or activation of the PI3K pathway, wherein R1 to R8 are as defined."

The patent application was internationally filed on June 06, 2023, under International application No.PCT/US2023/024567.

Disclaimer: Curated by HT Syndication.